Investors Bag VNDA Even Cheaper Than Its Secondary Stock Offering
March 19, 2018 at 09:58 AM EDT
Looking back to 3 days ago, Vanda Pharmaceuticals Inc (VNDA) priced a 5,500,000 share secondary stock offering at $17.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..